Clinical Trials List
Protocol NumberOBI-902-001
Active
2025-08-01 - 2029-02-08
Recruiting3
-
Trial Applicant
OBI PHARMA, INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- TSU-YI CHAO Division of Hematology & Oncology
- 蔡承志 Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
- 莊博雅 Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching Yun Hsieh Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Lun Chang Division of Hematology & Oncology
- 蕭炳坤 Division of General Surgery
- Tzeon-jye Chiou Division of Hematology & Oncology
- Wei-Wen Chang Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
111 participants
